Anti-IgE therapy as novel target for asthma-COPD overlap syndrome: More questions before celebration

Yang XiaDepartment of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University, School of MedicineHangzhou, Zhejiang, China, [email protected]

Wen LiDepartment of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University, School of MedicineHangzhou, Zhejiang, China, [email protected]

Huahao ShenDepartment of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University, School of MedicineHangzhou, Zhejiang, China, [email protected]

References

Tat TS, Cilli A. Omalizumab treatment in asthma-COPD overlap syndrome. J Asthma; 53(10):1048–1050. Epub 2016/05/05. doi: 10.1080/02770903.2016.1178281. PubMed PMID: 27144514.
Web of Science ®Google Scholar
Yalcin AD, Celik B, Yalcin AN. Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels. Immunopharmacol Immunotoxicol 2016;38(3):253–236. Epub 2016/04/29. doi: 10.3109/08923973.2016.1173057. PubMed PMID: 27121601.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Anti-IgE therapy as novel target for asthma-COPD overlap syndrome: More questions before celebration

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Anti-IgE therapy as novel target for asthma-COPD overlap syndrome: More questions before celebration

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date